BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10383924)

  • 1. Characterization of human small intestinal cytochromes P-450.
    Zhang QY; Dunbar D; Ostrowska A; Zeisloft S; Yang J; Kaminsky LS
    Drug Metab Dispos; 1999 Jul; 27(7):804-9. PubMed ID: 10383924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of cytochrome P4501A1 expression in rat small intestine.
    Zhang QY; Wikoff J; Dunbar D; Fasco M; Kaminsky L
    Drug Metab Dispos; 1997 Jan; 25(1):21-6. PubMed ID: 9010625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of rat small intestinal cytochrome P450 composition and inducibility.
    Zhang QY; Wikoff J; Dunbar D; Kaminsky L
    Drug Metab Dispos; 1996 Mar; 24(3):322-8. PubMed ID: 8820423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of mouse small intestinal cytochrome P450 expression.
    Zhang QY; Dunbar D; Kaminsky LS
    Drug Metab Dispos; 2003 Nov; 31(11):1346-51. PubMed ID: 14570766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP3A in horse intestines.
    Tydén E; Olsén L; Tallkvist J; Larsson P; Tjälve H
    Toxicol Appl Pharmacol; 2004 Dec; 201(2):112-9. PubMed ID: 15541751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic characterization of the major human small intestinal cytochrome p450s.
    Obach RS; Zhang QY; Dunbar D; Kaminsky LS
    Drug Metab Dispos; 2001 Mar; 29(3):347-52. PubMed ID: 11181505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450-mediated metabolism in the human gut wall.
    Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase 1 and phase 2 metabolic activities along the small intestine in adult male sheep.
    Maté L; Virkel G; Lifschitz A; Sallovitz J; Ballent M; Lanusse C
    J Vet Pharmacol Ther; 2010 Dec; 33(6):537-45. PubMed ID: 21062305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mRNA expression of cytochrome P450 isoforms in human gastric tissue.
    Canturk P; Caner V; Oruc N; Akarca US; Tepeli E; Cetin OG; Zencir S; Topcu Z
    Hepatogastroenterology; 2010; 57(98):372-6. PubMed ID: 20583446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shed human enterocytes as a tool for the study of expression and function of intestinal drug-metabolizing enzymes and transporters.
    Glaeser H; Drescher S; van der Kuip H; Behrens C; Geick A; Burk O; Dent J; Somogyi A; Von Richter O; Griese EU; Eichelbaum M; Fromm MF
    Clin Pharmacol Ther; 2002 Mar; 71(3):131-40. PubMed ID: 11907487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the cytochrome P450 (CYP)-mediated metabolic properties of miocamycin: evaluation of the possibility of a metabolic intermediate complex formation with CYP, and identification of the human CYP isoforms.
    Kasahara M; Suzuki H; Komiya I
    Drug Metab Dispos; 2000 Apr; 28(4):409-17. PubMed ID: 10725309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat small intestinal cytochromes P450 probed by warfarin metabolism.
    Fasco MJ; Silkworth JB; Dunbar DA; Kaminsky LS
    Mol Pharmacol; 1993 Feb; 43(2):226-33. PubMed ID: 8429825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 expression and activities in human tongue cells and their modulation by green tea extract.
    Yang SP; Raner GM
    Toxicol Appl Pharmacol; 2005 Jan; 202(2):140-50. PubMed ID: 15629189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens.
    von Richter O; Burk O; Fromm MF; Thon KP; Eichelbaum M; Kivistö KT
    Clin Pharmacol Ther; 2004 Mar; 75(3):172-83. PubMed ID: 15001968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues.
    Bièche I; Narjoz C; Asselah T; Vacher S; Marcellin P; Lidereau R; Beaune P; de Waziers I
    Pharmacogenet Genomics; 2007 Sep; 17(9):731-42. PubMed ID: 17700362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytochrome P-450 metabolism of retinals to retinoic acids.
    Zhang QY; Dunbar D; Kaminsky L
    Drug Metab Dispos; 2000 Mar; 28(3):292-7. PubMed ID: 10681373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches.
    Venkatakrishnan K; von Moltke LL; Court MH; Harmatz JS; Crespi CL; Greenblatt DJ
    Drug Metab Dispos; 2000 Dec; 28(12):1493-504. PubMed ID: 11095589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative aflatoxin B(1) activation and cytotoxicity in human bronchial cells expressing cytochromes P450 1A2 and 3A4.
    Van Vleet TR; Macé K; Coulombe RA
    Cancer Res; 2002 Jan; 62(1):105-12. PubMed ID: 11782366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties and regional expression of a CYP3A-like protein in channel catfish intestine.
    James MO; Lou Z; Rowland-Faux L; Celander MC
    Aquat Toxicol; 2005 May; 72(4):361-71. PubMed ID: 15848255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal drug transporter expression and the impact of grapefruit juice in humans.
    Glaeser H; Bailey DG; Dresser GK; Gregor JC; Schwarz UI; McGrath JS; Jolicoeur E; Lee W; Leake BF; Tirona RG; Kim RB
    Clin Pharmacol Ther; 2007 Mar; 81(3):362-70. PubMed ID: 17215845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.